GGrantIndex
← Leaderboards

Ethan M. Basch

Univ Of North Carolina Chapel Hill

$11,364,971
Attributed
$15,754,470
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200825
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,754,470 · 8

By mechanism

N02$5,219,546 · 2
U01$2,957,475 · 1
T32$2,664,328 · 1
R25$2,147,741 · 1
N01$1,769,778 · 1
K07$769,228 · 1

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Cancer Care

Research focus

Cancer CarePatient Outcomes AssessmentsReportingResearch PersonnelPatient OrientedEvaluationParticipantFosteringIndustryMalignant NeoplasmsFundingProgramsCareerMultidisciplinarySkillsMentorsBaseAdverse EventSymptomsCareer DevelopmentCommon Terminology Criteria For Adverse EventsOutcomes ResearchClinical TrialsPatient Self-Report

Grant awards (35)

Cancer Care Quality Training Program$393,505
T32 · FY2025 · CA · contact PI
Cancer Prevention and Control Research Program$47,171
P30 · FY2025 · CA · contact PI
Cancer Care Quality Training Program$392,446
T32 · FY2024 · CA · contact PI
Cancer Prevention and Control Research Program$41,356
P30 · FY2024 · CA · contact PI
Cancer Care Quality Training Program$354,190
T32 · FY2023 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$269,200
U01 · FY2023 · CA · contact PI
Cancer Prevention and Control Research Program$45,949
P30 · FY2023 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$554,283
U01 · FY2022 · CA · contact PI
Cancer Care Quality Training Program$307,012
T32 · FY2022 · CA · contact PI
Cancer Prevention and Control Research Program$45,949
P30 · FY2022 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$469,493
U01 · FY2021 · CA · contact PI
Cancer Care Quality Training Program$336,552
T32 · FY2021 · CA · contact PI
Cancer Prevention and Control Research Program$45,949
P30 · FY2021 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$530,934
U01 · FY2020 · CA · contact PI
Cancer Care Quality Training Program$256,704
T32 · FY2020 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$537,655
U01 · FY2019 · CA · contact PI
Cancer Care Quality Training Program$279,745
T32 · FY2019 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$595,910
U01 · FY2018 · CA · contact PI
Cancer Care Quality Training Program$344,174
T32 · FY2018 · CA · contact PI
Cancer Care Quality Research Training Program$401,402
R25 · FY2017 · CA · contact PI
Cancer Care Quality Research Training Program$405,045
R25 · FY2016 · CA · contact PI
Cancer Care Quality Research Training Program$429,798
R25 · FY2015 · CA · contact PI
PATIENT REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY$1,769,778
N01 · FY2014 · CA · contact PI
Cancer Care Quality Research Training Program$454,498
R25 · FY2014 · CA
Cancer Care Quality Research Training Program$456,998
R25 · FY2013 · CA
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting$133,330
K07 · FY2012 · CA · contact PI
TAS::75 0849::TAS - PATIENT REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY$1,769,778
N02 · FY2011 · CA · contact PI
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting$133,978
K07 · FY2011 · CA · contact PI
TAS::75 0849::TAS - PATIENT REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY$1,537,770
N02 · FY2010 · CA · contact PI
R&D-OTHER R & D-A RES/EXPL DEV$862,190
N02 · FY2010 · CA · contact PI
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting$133,978
K07 · FY2010 · CA · contact PI
R&D-OTHER R & D-A RES/EXPL DEV$1,049,808
N02 · FY2009 · CA · contact PI
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting$133,972
K07 · FY2009 · CA · contact PI
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting$99,992
K07 · FY2009 · CA · contact PI
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting$133,978
K07 · FY2008 · CA · contact PI